Guggenheim Capital LLC Dr Reddys Laboratories LTD Transaction History

Guggenheim Capital LLC

  • $12 Billion
  • Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Guggenheim Capital LLC holds 106,538 shares of RDY stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
106,538
Previous 24,144 341.26%
Holding current value
$1.39 Million
Previous $1.92 Million 12.3%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$13.99 - $79.75 $1.15 Million - $6.57 Million
82,394 Added 341.26%
106,538 $1.68 Million
Q3 2024

Nov 13, 2024
BUY
$75.41 - $84.21 $99,088 - $110,651
1,314 Added 5.76%
24,144 $1.92 Million
Q2 2024

Aug 14, 2024
BUY
$68.26 - $76.19 $45,597 - $50,894
668 Added 3.01%
22,830 $1.74 Million
Q1 2024

May 14, 2024
SELL
$67.36 - $77.59 $144,891 - $166,896
-2,151 Reduced 8.85%
22,162 $1.63 Million
Q4 2023

Feb 14, 2024
BUY
$64.27 - $69.9 $70,568 - $76,750
1,098 Added 4.73%
24,313 $1.69 Million
Q3 2023

Nov 14, 2023
BUY
$61.9 - $72.77 $145,774 - $171,373
2,355 Added 11.29%
23,215 $1.55 Million
Q2 2023

Aug 11, 2023
BUY
$53.34 - $63.11 $332,041 - $392,859
6,225 Added 42.54%
20,860 $1.32 Million
Q1 2023

May 10, 2023
BUY
$51.63 - $56.93 $509,226 - $561,500
9,863 Added 206.68%
14,635 $833,000
Q4 2022

Feb 14, 2023
SELL
$51.15 - $57.45 $8,184 - $9,192
-160 Reduced 3.24%
4,772 $246,000
Q3 2022

Nov 14, 2022
SELL
$49.9 - $57.32 $18,862 - $21,666
-378 Reduced 7.12%
4,932 $258,000
Q2 2022

Aug 15, 2022
BUY
$49.62 - $58.13 $78,697 - $92,194
1,586 Added 42.59%
5,310 $294,000
Q1 2022

May 16, 2022
BUY
$48.27 - $65.25 $179,757 - $242,991
3,724 New
3,724 $207,000
Q3 2021

Nov 15, 2021
SELL
$60.19 - $75.29 $200,492 - $250,790
-3,331 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$62.12 - $74.2 $206,921 - $247,160
3,331 New
3,331 $245,000
Q1 2021

May 13, 2021
SELL
$57.98 - $73.08 $180,897 - $228,009
-3,120 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$62.61 - $71.29 $5,008 - $5,703
80 Added 2.63%
3,120 $223,000
Q3 2020

Nov 13, 2020
BUY
$51.39 - $72.41 $156,225 - $220,126
3,040 New
3,040 $211,000
Q2 2018

Aug 14, 2018
SELL
$28.49 - $35.06 $252,506 - $310,736
-8,863 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$31.93 - $39.54 $46,905 - $58,084
-1,469 Reduced 14.22%
8,863 $290,000
Q4 2017

Feb 14, 2018
BUY
$34.15 - $37.62 $25,339 - $27,914
742 Added 7.74%
10,332 $388,000
Q3 2017

Nov 14, 2017
BUY
$30.11 - $37.72 $288,754 - $361,734
9,590
9,590 $342,000

Others Institutions Holding RDY

# of Institutions
264
Shares Held
107M
Call Options Held
71K
Put Options Held
22.5K
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.17B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email